Obesity does not influence hepcidin and hemojuvelin levels in hemodialysis patients

Nephron - Clinical Practice

Volumn 124, Issue 3-4, 2013, Pages 159-166

  Sarafidis, Pantelis A ^a   Rumjon, Adam ^a   Ackland, Daniel ^a   MacLaughlin, Helen L ^a,b   Bansal, Sukhvinder S ^c   Brasse Lagnel, Carole ^d   Macdougall, Iain C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Division of Diabetes and Nutritional Sciences   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anemia; Hemodialysis; Hemojuvelin; Hepcidin; Iron; Obesity

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HEMOGLOBIN; HEMOJUVELIN; HEPCIDIN; IRON; TRANSFERRIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MALE; OBESITY; PRIORITY JOURNAL; RETICULOCYTE; TRANSFERRIN BLOOD LEVEL; INFLAMMATION; PROTEIN BLOOD LEVEL;

AGED; ANEMIA, IRON-DEFICIENCY; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GPI-LINKED PROTEINS; HEPCIDINS; HUMANS; MALE; MIDDLE AGED; OBESITY; RENAL DIALYSIS;

EID: 84908300062     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000355545     Document Type: Article

References (38)

1. Lee PL, Beutler E: Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 2009; 4: 489-515.
2. Macdougall IC, Malyszko J, Hider RC, Bansal SS: Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1681-1689.
3. Fleming MD: The regulation of hepcidin and its effects on systemic and cellular iron metabolism. Hematology Am Soc Hematol Educ Program 2008;151-158.
4. Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR: Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 2005; 106: 1092-1097. (Pubitemid 41076459)
5. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C: Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 2011; 140: 1261-1271.
6. Malyszko J: Hemojuvelin: the hepcidin story continues. Kidney Blood Press Res 2009; 32: 71-76.
7. Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T: Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 2008; 40: 122-131. (Pubitemid 350193320)
8. Silvestri L, Pagani A, Camaschella C: Furinmediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008; 111: 924-931.
9. Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G: Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy. Eur J Clin Invest 2009; 39: 883-890.
10. Eleftheriadis T, Liakopoulos V, Antoniadi G, Kartsios C, Stefanidis I: The role of hepcidin in iron homeostasis and anemia in hemodialysis patients. Semin Dial 2009; 22: 70-77.
11. Chawla LS, Krishnan M: Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodial Int 2009; 13: 222-234.
12. Rumjon A, Sarafidis PA, Brincat S, Musto R, Malyszko J, Bansal SS, Macdougall IC: The role of hemojuvelin for assessment of iron homoeostasis in advanced nephropathy. Am J Nephrol 2012; 35:295-304.
13. Wenzel BJ, Stults HB, Mayer J: Hypoferraemia in obese adolescents. Lancet 1962; 2: 327-328.
14. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104-108. (Pubitemid 38857573)
15. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN Jr: Serum iron and body fat distribution in a multiethnic cohort of adults living in New York City. J Am Diet Assoc 2006; 106: 680-684.
16. Zafon C, Lecube A, Simo R: Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev 2010; 11: 322-328.
17. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben AI, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788-796. (Pubitemid 44316823)
18. Sarafidis PA, Rumjon A, Maclaughlin HL, Macdougall IC: Obesity and iron deficiency in chronic kidney disease: the putative role of hepcidin. Nephrol Dial Transplant 2012; 27: 50-57.
19. del Giudice EM, Santoro N, Amato A, Brienza C, Calabro P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L: Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009; 94: 5102-5107.
20. Aeberli I, Hurrell RF, Zimmermann MB: Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes (Lond) 2009; 33: 1111-1117.
21. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Guzman G, Holterman AX, Braunschweig C: Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring) 2010; 18: 1449-1456.
22. Amato A, Santoro N, Calabro P, Grandone A, Swinkels DW, Perrone L, del Giudice EM: Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes (Lond) 2010; 34: 1772-1774.
23. Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C, Ayloo S, Vitello J, Braunschweig C: Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity (Silver Spring) 2010; 18: 2010-2016.
24. Luciani N, Brasse-Lagnel C, Poli M, Anty R, Lesueur C, Cormont M, Laquerriere A, Folope V, Lemarchand-Brustel Y, Gugenheim J, Gual P, Tran A, Bekri S: Hemojuvelin: a new link between obesity and iron homeostasis. Obesity (Silver Spring) 2011; 19: 1545-1551.
25. Peters H, Rumjon A, Bansal SS, Laarakkers S, van den Brand JA, Sarafidis PA, Musto R, Malyszko J, Swinkels DW, Wetzels J, Macdougall IC: Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA. Nephrol Dial Transplant 2012; 27: 3923-3929.
26. Bansal SS, Abbate V, Bomford A, Halket JM, Macdougall IC, Thein SL, Hider RC: Quantitation of hepcidin in serum using ultra-highpressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010; 24: 1251-1259.
27. Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M: Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27: 416-418. (Pubitemid 36384882)
28. Ausk KJ, Ioannou GN: Is obesity associated with anemia of chronic disease? A population-based study. Obesity (Silver Spring) 2008; 16: 2356-2361.
29. Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I, Hurrell RF: Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes (Lond) 2008; 32: 1098-1104. (Pubitemid 351986198)
30. Iwasaki T, Nakajima A, Yoneda M, Yamada Y, Mukasa K, Fujita K, Fujisawa N, Wada K, Terauchi Y: Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005; 28: 2486-2491. (Pubitemid 41384298)
31. Wrede CE, Buettner R, Bollheimer LC, Scholmerich J, Palitzsch KD, Hellerbrand C: Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006; 154: 333-340.
32. Vokurka M, Lacinova Z, Kremen J, Kopecky P, Blaha J, Pelinkova K, Haluzik M, Necas E: Hepcidin expression in adipose tissue increases during cardiac surgery. Physiol Res 2010; 59: 393-400.
33. Hintze KJ, Snow D, Nabor D, Timbimboo H: Adipocyte hypoxia increases hepatocyte hepcidin expression. Biol Trace Elem Res 2010; 143: 764-771.
34. Chung B, Matak P, McKie AT, Sharp P: Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007; 137: 2366-2370. (Pubitemid 350058702)
35. Eleftheriadis T, Kartsios C, Yiannaki E, Kazila P, Antoniadi G, Liakopoulos V, Markala D: Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am J Nephrol 2008; 28: 152-157. (Pubitemid 350126506)
36. Miyamoto T, Carrero JJ, Stenvinkel P: Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens 2011; 20: 662-668.
37. Costa E, Swinkels DW, Laarakkers CM, Rocha-Pereira P, Rocha S, Reis F, Teixeira F, Miranda V, do Sameiro FM, Loureiro A, Quintanilha A, Belo L, Santos-Silva A: Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol 2009; 122: 226-229.
38. Chełchowska M, Lewandowski L, Ambroszkiewicz J, Swiatek E, Gajewska J, Ołtarzewski M, Laskowska-Klita T: The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs (in Polish). Przegl Lek 2008; 65: 474-478.